IBDEI1Z6 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,33517,1,4,0)
 ;;=4^I69.928
 ;;^UTILITY(U,$J,358.3,33517,2)
 ;;=^5007557
 ;;^UTILITY(U,$J,358.3,33518,0)
 ;;=I69.328^^131^1671^23
 ;;^UTILITY(U,$J,358.3,33518,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33518,1,3,0)
 ;;=3^Speech/Lang Deficit Following Cerebvasc Infarc
 ;;^UTILITY(U,$J,358.3,33518,1,4,0)
 ;;=4^I69.328
 ;;^UTILITY(U,$J,358.3,33518,2)
 ;;=^5007495
 ;;^UTILITY(U,$J,358.3,33519,0)
 ;;=E04.0^^131^1672^39
 ;;^UTILITY(U,$J,358.3,33519,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33519,1,3,0)
 ;;=3^Nontoxic Diffuse Goiter
 ;;^UTILITY(U,$J,358.3,33519,1,4,0)
 ;;=4^E04.0
 ;;^UTILITY(U,$J,358.3,33519,2)
 ;;=^5002477
 ;;^UTILITY(U,$J,358.3,33520,0)
 ;;=E04.1^^131^1672^41
 ;;^UTILITY(U,$J,358.3,33520,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33520,1,3,0)
 ;;=3^Nontoxic Single Thyroid Nodule
 ;;^UTILITY(U,$J,358.3,33520,1,4,0)
 ;;=4^E04.1
 ;;^UTILITY(U,$J,358.3,33520,2)
 ;;=^5002478
 ;;^UTILITY(U,$J,358.3,33521,0)
 ;;=E04.2^^131^1672^40
 ;;^UTILITY(U,$J,358.3,33521,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33521,1,3,0)
 ;;=3^Nontoxic Multinodular Goiter
 ;;^UTILITY(U,$J,358.3,33521,1,4,0)
 ;;=4^E04.2
 ;;^UTILITY(U,$J,358.3,33521,2)
 ;;=^267790
 ;;^UTILITY(U,$J,358.3,33522,0)
 ;;=E01.1^^131^1672^36
 ;;^UTILITY(U,$J,358.3,33522,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33522,1,3,0)
 ;;=3^Iodine-Deficiency Related Multinodular (Endemic) Goiter
 ;;^UTILITY(U,$J,358.3,33522,1,4,0)
 ;;=4^E01.1
 ;;^UTILITY(U,$J,358.3,33522,2)
 ;;=^5002465
 ;;^UTILITY(U,$J,358.3,33523,0)
 ;;=E05.00^^131^1672^56
 ;;^UTILITY(U,$J,358.3,33523,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33523,1,3,0)
 ;;=3^Thyrotoxicosis w/ Diffuse Goiter w/o Thyrotoxic Crisis
 ;;^UTILITY(U,$J,358.3,33523,1,4,0)
 ;;=4^E05.00
 ;;^UTILITY(U,$J,358.3,33523,2)
 ;;=^5002481
 ;;^UTILITY(U,$J,358.3,33524,0)
 ;;=E05.01^^131^1672^55
 ;;^UTILITY(U,$J,358.3,33524,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33524,1,3,0)
 ;;=3^Thyrotoxicosis w/ Diffuse Goiter w/ Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,33524,1,4,0)
 ;;=4^E05.01
 ;;^UTILITY(U,$J,358.3,33524,2)
 ;;=^5002482
 ;;^UTILITY(U,$J,358.3,33525,0)
 ;;=E05.90^^131^1672^58
 ;;^UTILITY(U,$J,358.3,33525,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33525,1,3,0)
 ;;=3^Thyrotoxicosis,Unspec w/o Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,33525,1,4,0)
 ;;=4^E05.90
 ;;^UTILITY(U,$J,358.3,33525,2)
 ;;=^5002492
 ;;^UTILITY(U,$J,358.3,33526,0)
 ;;=E05.91^^131^1672^57
 ;;^UTILITY(U,$J,358.3,33526,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33526,1,3,0)
 ;;=3^Thyrotoxicosis,Unspec w/ Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,33526,1,4,0)
 ;;=4^E05.91
 ;;^UTILITY(U,$J,358.3,33526,2)
 ;;=^5002493
 ;;^UTILITY(U,$J,358.3,33527,0)
 ;;=E89.0^^131^1672^50
 ;;^UTILITY(U,$J,358.3,33527,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33527,1,3,0)
 ;;=3^Postprocedural Hypothyroidism
 ;;^UTILITY(U,$J,358.3,33527,1,4,0)
 ;;=4^E89.0
 ;;^UTILITY(U,$J,358.3,33527,2)
 ;;=^5003035
 ;;^UTILITY(U,$J,358.3,33528,0)
 ;;=E03.2^^131^1672^32
 ;;^UTILITY(U,$J,358.3,33528,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33528,1,3,0)
 ;;=3^Hypothyroidism d/t Meds/Oth Exogenous Substances
 ;;^UTILITY(U,$J,358.3,33528,1,4,0)
 ;;=4^E03.2
 ;;^UTILITY(U,$J,358.3,33528,2)
 ;;=^5002471
 ;;^UTILITY(U,$J,358.3,33529,0)
 ;;=E03.9^^131^1672^33
 ;;^UTILITY(U,$J,358.3,33529,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,33529,1,3,0)
 ;;=3^Hypothyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,33529,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,33529,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,33530,0)
 ;;=E06.0^^131^1672^53
